Home/Filings/4/0001209191-23-050435
4//SEC Filing

Aguillard Mark Bryan 4

Accession 0001209191-23-050435

CIK 0001651944other

Filed

Sep 21, 8:00 PM ET

Accepted

Sep 22, 8:45 PM ET

Size

8.0 KB

Accession

0001209191-23-050435

Insider Transaction Report

Form 4
Period: 2023-09-20
Aguillard Mark Bryan
Chief Commercial Officer
Transactions
  • Award

    Common Stock

    2023-09-20+90,00090,000 total
  • Award

    Stock Option (right to buy)

    2023-09-20+90,00090,000 total
    Exercise: $1.69Exp: 2033-09-20Common Stock (90,000 underlying)
Footnotes (2)
  • [F1]The securities awarded are in the form of restricted stock units issued pursuant to the issuer's 2022 Inducement Plan, as amended. Each restricted stock unit represents a contingent right to receive one share of issuer common stock. Subject to the reporting person's continued service, (i) twelve forty-eighths (12/48) of the restricted stock units shall vest on September 20, 2024 and (ii) the remaining the remaining thirty-six forty-eighths (36/48) shall vest in twelve (12) equal installments of three forty-eighths (3/48) on the twentieth day of each third month following September 20, 2024 until the final vesting date on September 20, 2027.
  • [F2]Subject to the reporting person's continued service, (i) twelve forty-eighths (12/48) of the shares of issuer common stock exercisable pursuant to this option shall vest on September 20, 2024 and (ii) the remaining thirty-six forty-eighths (36/48) shall vest in a series of thirty-six (36) equal monthly installments of one forty-eighth (1/48) over the thirty-six (36) months thereafter until the final vesting date on September 20, 2027.

Issuer

DermTech, Inc.

CIK 0001651944

Entity typeother

Related Parties

1
  • filerCIK 0001993112

Filing Metadata

Form type
4
Filed
Sep 21, 8:00 PM ET
Accepted
Sep 22, 8:45 PM ET
Size
8.0 KB